Background: Little is known about the occurrence of bloodstream infections in hospitalized
patients with COVID-19 and the related clinical consequences. The aim of this systematic …

Abstract Objective Coronavirus disease 2019 (COVID‐19) has rapidly spread worldwide, but
there is so far no comprehensive analysis of all known symptoms of the disease. Our study …

Objective A meta-analysis of laboratory cardiac markers for multisystem inflammatory
syndrome in children (MIS-C) was performed in patients with coronavirus disease 2019 …

Background The hospitalization of children during the COVID-19 pandemic has affected
their physical and mental health. Pediatric nurses have faced challenges in providing high …

Abstract Coronavirus disease 2019 (COVID-19) has been circulating in many countries
around the world, characterized by long incubation period, strong infectivity, strong …

Compared to adults, severe or fatal COVID-19 disease is much less common in children.
However, a higher risk for progression has been reported in infants. Different pediatric …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the novel
respiratory disease COVID-19, has reached pandemic status and presents a wide range of …

Mid-regional proadrenomedullin (MR-proADM) is a new biomarker of endothelial damage
and its clinical use is increasing in sepsis and respiratory infections and recently in SARS …

Background: since December 2019, the world has become victim of the coronavirus disease
2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus-2 …

Background: Given the potential for additional development to clarify a better knowledge of
generally influence of COVID-19 upon the pediatric population, the clinical symptoms of …